Section R9-6-341. Human Immunodeficiency Virus (HIV) Infec- tion and Related Disease

A.      Case control measures:

1.        A local health agency shall:

a.        Conduct an epidemiologic investigation of each reported HIV-infected individual or suspect  case; and

b.        For each HIV-infected individual, submit to the Department, as specified in Article 2, Table 4, the information required under R9-6-206(D).

2.        The operator of a blood bank, blood center, or plasma center shall notify a donor of a test result with significant evidence suggestive of HIV infection, as required under

A.R.S. § 32-1483 and 21 CFR 630.6.

3.        The Department and a local health agency shall offer anonymous HIV-testing to an individual as specified in R9-6-1005.

B.       Contact  control  measures:  The  Department   or  the  Depart- ment’s  designee  shall  confidentially  notify  an  individual

reported to be at risk for HIV infection under A.R.S. § 36- 664(J) as specified in R9-6-1006(A).

C.      Environmental control measures: An employer, as defined under A.R.S. § 23-401, or health care provider shall comply with the requirements specified in A.R.S. § 23-403 and A.A.C. R20-5-602.

Historical Note

Renumbered from R9-6-734 and amended effective October 19, 1993 (Supp. 93-4). Former Section R9-6-341 renumbered to R9-6-344; new Section R9-6-341 renum- bered from R9-6-338 and amended effective April 4, 1997 (Supp. 97-2). Former R9-6-341 renumbered to R9- 6-349; new R9-6-341 renumbered from R9-6-333 and amended by final rulemaking at 10 A.A.R. 3559, effec- tive October 2, 2004 (Supp. 04-3). Former R9-6-341 renumbered to R9-6-344; new R9-6-341 renumbered from R9-6-339 and amended by final rulemaking at 14

A.A.R. 1502, effective April 1, 2008 (Supp. 08-2).